Abstract Narcolepsy type 1 (NT1) is a chronic sleep disorder resulting from the loss of a small population of hypothalamic neurons that produce wake-promoting hypocretin (HCRT; …
T cells respond to threats in an antigen-specific manner using T cell receptors (TCRs) that recognize short peptide antigens presented on major histocompatibility complex (MHC) …
L Barateau, F Pizza, G Plazzi… - Journal of Sleep …, 2022 - Wiley Online Library
This article addresses the clinical presentation, diagnosis, pathophysiology and management of narcolepsy type 1 and 2, with a focus on recent findings. A low level of …
T Schirinzi, D Landi, C Liguori - Journal of neurology, 2021 - Springer
SARS-CoV2 infection is responsible for a complex clinical syndrome, named Coronavirus Disease 2019 (COVID-19), whose main consequences are severe pneumonia and acute …
The orexin system comprises two G protein-coupled receptors, orexin 1 receptor (OX1R) and orexin 2 receptor (OX2R), along with two endogenous agonists cleaved from a common …
Z Zhang, Y Dauvilliers, G Plazzi, G Mayer… - Nature and science of …, 2022 - Taylor & Francis
Purpose Narcolepsy type-1 (NT1) is a rare chronic neurological sleep disorder with excessive daytime sleepiness (EDS) as usual first and cataplexy as pathognomonic …
Abstract Narcolepsy type 1 (NT1) and type 2 (NT2), also known as narcolepsy with and without cataplexy, are sleep disorders that benefited from major scientific advances over the …
Narcolepsy is a rare chronic neurological disorder characterized by an irresistible excessive daytime sleepiness and cataplexy. The disease is considered to be the result of the selective …
A Iranzo - Neuropsychopharmacology, 2020 - nature.com
Neurological autoimmune diseases are characterized by an inappropriate immune response that by mistake targets the nervous system. As a result, patients experiment a …